Amir Tursunovic

Dr. Amir Tursunovic

University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina, Federation of, Bosnia and Herzegovina
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2026 in Medicinski Glasnik
Verified
Journal Article
Open access
PDF file
ATAmir Tursunovic
Amir Tursunovic
KLKenana Ljuca
Kenana Ljuca
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
MBMinela Becirovic Becirovic
Minela Becirovic Becirovic
NLNadina Ljuca
Nadina Ljuca
BHBahrudin Hadžiefendić
Bahrudin Hadžiefendić
Aim: To compare outcomes of elective open inguinal hernia repair under local anaesthesia (LA) and general anaesthesia (GA). Methods: This retrospective cohort included 833 adults treated in Tuzla during 2017–2025. The primary outcome was any early adverse outcome within 30 days. Secondary outcomes included analgesic requirement, chronic groin pain, discomfort, dissatisfaction, and recurrence. Logistic regression adjusted for age, American Society of Anesthesiologists physical status, hernia characteristics, and technique. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were reported; Benjamini-Hochberg correction was applied to secondary outcomes. Results: The LA group included 425 patients and the GA group 408. Postoperative analgesia was required in 338 (79.5%) and 110 (27.0%) patients, respectively (p<0.001). An early adverse outcome occurred in 79 (18.6%) and 35 (8.6%) patients (aOR 2.08, 95% CI 1.31–3.30; p = 0.002), mainly because of more haematomas with LA, 54 (12.7%) versus 20 (4.9%) (p < 0.001). Chronic groin pain did not differ after adjustment (aOR 1.26, 95% CI 0.81–1.96; p = 0.310). Dissatisfaction was higher with LA, 85 (20.8%) versus 40 (10.1%) (aOR 1.95, 95% CI 1.27–2.99; p = 0.002). Eight recurrences were recorded. Median follow-up was 14 months (interquartile range 12–18 months). Conclusion: LA was associated with more early adverse outcomes and dissatisfaction than GA. Chronic pain did not differ after adjustment, and recurrence was similar. Selection bias and residual confounding should be considered.

20 November 2024 in South-East Europe Endo-Surgery Journal
Verified
Journal Article
Open access
ATAmir Tursunovic
Amir Tursunovic
The basic method of treating patients with pancreatic tumors is surgery, which involves complete removal of the tumor. The growing experience of surgeons and improved technical capabilities make it possible to perform extensive resections without increasing the complication rate. Whipple's pancreaticoduodenectomy remains the standard treatment method for patients with a head tumor or an uncinate process of the pancreas. Modifications of this method that allow preservation of the pylorus do not affect long-term oncological results. Involvement of large arterial vessels was a contraindication for resection in patients with pancreatic tumors. Involvement of the middle mesenteric vein is not in itself a criterion of inoperability. Current surgical practices have described a regional pancreatectomy approach that includes "en bloc" resection of the peripancreatic soft tissue, regional lymph nodes with resection of the portal vein, and the superior mesenteric artery. "Minimally invasive" surgical procedures, performed through a small incision, are preferred in the treatment of pancreatic tumors. The technologies used today are considered the most important developments in modern surgery and offer many advantages for patients and doctors compared to classic open surgery. Laparoscopic and robotic surgery, compared to open surgery, minimize the length of hospital stay and offer the patient a faster recovery.

3 June 2022 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
FLFarid Ljuca
Farid Ljuca
ATAmir Tursunovic
Amir Tursunovic
KLKenana Ljuca
Kenana Ljuca
ZRZijah Rifatbegović
Zijah Rifatbegović
MAMirha Agić
Mirha Agić
The association between urine amylase levels and the development of postoperative complications after Whipple resection is still unknown. Aim of this study was to determine the prognostic value of urine amylase levels for postoperative complications in patients who underwent Whipple resection. In this retrospective cohort study, we analyzed amylase levels in urine, serum and drains in 52 patients who underwent Whipple resection preoperatively and on Postoperative Day 1 (POD1) after the intervention. Patients were followed up for 3 months to assess their predictive value for postoperative complications. In patients with complications, urine amylase levels were significantly higher on POD1 than before resection (198.89 ± 28.41 vs. 53.70 ± 7.44, p=0.000). Considering the sensitivity and specificity of the urine amylase level on POD1, an area under the ROC curve of 0.918 was obtained (p<0.001, 95% CI: 0.894-0.942). Patients with urine amylase levels ³140.00 U/L had significantly higher risks of postoperative pancreatic fistula (POPF) grade C (definition of POPF done according to the ISGP) (RR:20.26; 95% CI: 1.18-347.07; p=0.038), readmission to hospital (RR: 6.61; 95% CI: 1.53-28.58; p=0.011), reoperation (RR: 5.67; 95% CI: 1.27-25.27; p=0.023), and mortality (RR:17.00; 95% CI: 2.33-123.80; p=0.005) than patients with urine amylase levels <140.00 U/L. Urine amylase levels on POD1 displayed strong and significant positive correlations with serum amylase levels (r=0.92, p=0.001) and amylase levels in drains (r=0.86, p=0.002). We can conclude that urine amylase levels on POD1 have good prognostic value for postoperative complications after Whipple resection and might be used as an additional predictive risk factor.

30 September 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
ABAmmar Brkic
Ammar Brkic
KLKenana Ljuca
Kenana Ljuca
ETEmir Tulumović
Emir Tulumović
NLNadina Ljuca
Nadina Ljuca
Nermin SalkicNermin Salkic
Nermin Salkic
BHBahrudin Hadžiefendić
Bahrudin Hadžiefendić
Background/aim: Hemodialysis patients face a high burden of cardiovascular diseases, which account for over 40% of mortality in this population. In these patients, approximately two-thirds of cardiovascular deaths are due to arrhythmia. The aim of this study was to determine whether the ultrafiltration rate is associated with morphological and functional parameters of the left heart and arrhythmias. Methods: This work was a cross-sectional observational clinical study, with 75 hemodialysis patients. Patients were divided into two groups based on ultrafiltration rate (UFR): higher-UFR group, ultrafiltration rate ≥ 10 mL/kg/h (n = 37); lower-UFR group, ultrafiltration rate < 10 mL/kg/h (n = 38). All patients were analyzed for myocardial morphological and functional parameters and arrhythmias. Results: Statistically significant higher values were observed for the left atrium diameter (LAD) (47.56 ± 4.82 vs. 44.75 ± 2.33 mm, p = 0.0019), the left atrial volume index (LAVI) (43.28 ± 7.13 vs. 36.43 ± 8.52 mL/m2, p = 0.0003), and the left ventricular mass index (LVMI) (138.47 ± 29.32 vs. 116.04 ± 31.64 g/m2, p = 0.0021) in the higher-UFR group. UFR was associated with LAD (OR: 3.6000, 95% CI: 1.3780–9.4053, p = 0.0089), LAVI (OR: 4.1067, 95% CI: 1.5478–10.8956, p = 0.0045), and LVMI (OR: 4.7619, 95% CI: 1.6825–13.4774, p = 0.0033). The frequency of ventricular and supraventricular arrhythmias was similar between the analyzed patient groups. Conclusions: Higher UFR was associated with structural changes in the left heart (LAVI, LAD, and LVMI), but not with other echocardiographic parameters or arrhythmias in hemodialysis patients.

4 August 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
MBMinela Becirovic Becirovic
Minela Becirovic Becirovic
ABAmir Bećirović
Amir Bećirović
ATAmir Tursunovic
Amir Tursunovic
ABAjla Bajrić
Ajla Bajrić
LFLamija Ferhatbegovic
Lamija Ferhatbegovic
Background/Objectives: Early risk stratification remains challenging in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The present study evaluated the prognostic value of 24 h high-sensitivity cardiac troponin I (hs-Troponin I) and assessed whether combining biomarkers and echocardiographic parameters improves short-term risk prediction. Methods: This prospective observational cohort study included 170 consecutive adult patients with confirmed NSTEMI who were admitted to a Medical Intensive Care Unit and prospectively enrolled between February 2022 and January 2023. Clinical, routine biochemical, inflammatory, hematological, lipid, and echocardiographic data were collected during index hospitalization. High-sensitivity cardiac troponin I was measured at admission and again 24 h after hospitalization, with the 24 h value used as the principal marker of myocardial injury in the prediction analyses. The primary endpoint was major adverse cardiovascular events (MACEs), defined as cardiovascular death, recurrent myocardial infarction, ischemic stroke, urgent coronary revascularization, or hospitalization for worsening heart failure, within 3 months. Multivariable logistic regression, Cox regression, sequential prediction modeling, and internal bootstrap validation were performed. Results: MACEs occurred in 88 patients (51.8%). Twenty-four-hour hs-Troponin I, but not admission hs-Troponin I, was independently associated with MACEs (OR 1.57, 95% CI 1.09–2.26; p = 0.015) and a shorter time to the first MACE event (HR 1.38, 95% CI 1.07–1.78; p = 0.012). Lower left ventricular ejection fraction (LVEF) was also independently associated with adverse outcomes. The addition of 24 h hs-Troponin I, LVEF, and C-reactive protein improved discrimination from an AUC of 0.665 to 0.759 (optimism-corrected AUC, 0.717), with corresponding improvements in reclassification. A simplified multimarker score was independently associated with event-free survival (HR 2.36, 95% CI 1.53–3.64; p < 0.001). Conclusions: In patients admitted to a medical intensive care unit with NSTEMI, the integration of 24 h hs-Troponin I, LVEF, and C-reactive protein improved short-term risk prediction beyond that of clinical variables alone. A practical multimarker model based on routinely available parameters identified patients at increased risk of adverse cardiovascular outcomes during early follow-up.